Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient

Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient

Bibliographic Details
Main Author:	Mishra A
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2008-01-01
Series:	Journal of Postgraduate Medicine
Online Access:	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2008;volume=54;issue=3;spage=237;epage=237;aulast=Mishra

Similar Items

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
by: Abdulmohsen H. Al Elq
Published: (2013-03-01)

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
by: Richhariya A, et al.
Published: (2012-02-01)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
by: Jarred Strickling, et al.
Published: (2019-04-01)

Zoledronic acid plus methylprednisolone zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial
by: Guoqi Cai, et al.
Published: (2019-10-01)

Severe Symptomatic Hypocalcemia from HIV Related Hypoparathyroidism
by: Sartaj Sandhu, et al.
Published: (2018-01-01)

Zoledronic acid in breast cancer: latest findings and interpretations
by: Michael Gnant
Published: (2011-11-01)

The evolving role of zoledronic acid in early breast cancer
by: Michael Gnant
Published: (2009-04-01)

Synergistic effect of nifedipine and magnesium sulfate causing symptomatic hypocalcemia in a preeclamptic patient
by: P Veena, et al.
Published: (2016-01-01)

SUBTROCHANTERIC FRACTURE IN A PATIENT RECEIVING ZOLEDRONIC ACID THERAPY FOR METASTATIC BREAST CANCER
by: Ishiguro, Naoki, et al.
Published: (2011)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
by: Ishikawa K, et al.
Published: (2018-10-01)

Acute uveitis following zoledronic acid infusion
by: Krishna Kumar Rathnam, et al.
Published: (2009-01-01)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
by: Aft R
Published: (2012-10-01)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
by: Xinmin Zhao, et al.
Published: (2015-09-01)

Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
by: El Saghir Nagi S, et al.
Published: (2005-12-01)

Effects of zoledronic acid (ZOL) and paclitaxelon (PAC) angiogenesis in breast cancer
by: Michailidou, Maria
Published: (2007)

Effect of intravenous administration of zoledronic acid on jaw bone density in cases having skeletal metastasis: A prospective clinical study
by: Veena Jain, et al.
Published: (2019-01-01)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
by: Allan Lipton
Published: (2011-03-01)

Effect of PPIs on symptomatic hypocalcemia after thyroidectomy: A retrospective cohort study
by: Daniel Gerges, et al.
Published: (2021-02-01)

Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.
by: Wei-Wei Huang, et al.
Published: (2012-01-01)

Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid
by: Masashi Yanae, et al.
Published: (2017-09-01)

Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report
by: Mingming Li, et al.
Published: (2019-09-01)

Postoperative hypocalcemia: analysis of factors influencing early hypocalcemia development following thyroid surgery
by: Paolo Del Rio, et al.
Published: (2019-04-01)

Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3 years
by: Chi Zhang, et al.
Published: (2018-11-01)

Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
by: Hsien Liu, et al.
Published: (2019-02-01)

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
by: Vessella Robert L, et al.
Published: (2006-01-01)

Intraoperative hypocalcemia following total thyroidectomy
by: Dr. Saravanan PA
Published: (2009-05-01)

Investigation of Intravenous Zoledronic Acid Therapy on Circulating Lymphocyte Subpopulation in Patients with Primary Osteoporosis: A Pilot Study
by: Min Cui, Ph. D, et al.
Published: (2021-01-01)

Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells
by: Salah A. Sheweita, PhD, et al.
Published: (2021-02-01)

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
by: Ayoub Charehbili, et al.
Published: (2013-10-01)

Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid
by: Jenny Sarah Schneider, et al.
Published: (2017-08-01)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
by: Ibrahim Toni, et al.
Published: (2012-11-01)

Role of autophagy in zoledronic acid-induced cell death in human breast cancer cells
by: Ying-Ying Wei, et al.
Published: (2010)

Histomorphometric Evaluation of Peri-Implant Bone Response to Intravenous Administration of Zoledronate (Zometa<sup>®</sup>) in an Osteoporotic Rat Model
by: Amani M. Basudan, et al.
Published: (2020-11-01)

Short-term intravenous zoledronic acid in severe osteogenesis imperfecta : A report of three siblings of children
by: Hadyanto Lim, et al.
Published: (2008-05-01)

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
by: Neelima Vidula, et al.
Published: (2021-09-01)

Severe hyperphosphatemia and symptomatic hypocalcemia after bowel cleansing with oral sodium phosphate solution in a patient with postoperative hypoparathyroidism
by: Berker Dilek, et al.
Published: (2010-02-01)

Mechanisms for zoledronic acid- and glucose deprivation-induced cell death in human breast cancer cells
by: Li-Lin Hsu, et al.
Published: (2018)

Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial
by: Susanne Crocamo, et al.
Published: (2019-05-01)

ZOLEDRONIC ACID ADMINISTRATION ENHANCES FRACTURE HEALING IN THE OSTEOPOROTIC FRACTURES IN OVARIECTOMIZED RABBITS
by: Cansabuncu Gokhan, et al.
Published: (2019-05-01)

Pharmacokinetics of Shikimic Acid Following Intragastric and Intravenous Administrations in Rats
by: Keumhan Noh, et al.
Published: (2020-08-01)